Multiple cutaneous squamous cell carcinoma in immunosuppressed vs immunocompetent patients
JAMA Mar 20, 2019
Gonzalez JL, et al. - Investigators researched the relationship between multiple squamous cell carcinoma (SCC) (the second most common skin cancer in the US) and the risk of poor consequences in a cohort of primarily immunocompetent subjects. SCC is considered a significant determinant of morbidity in immunosuppressed cases. They observed an higher risk of developing a subsequent SCC after the first incidence. They found a 65- to 100-fold increase in the incidence of SCC among immunosuppressed individuals.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries